Uroplasty Inc. (UPI)
-NasdaqCM 2.19 
0.01(0.34%) 1:41PM EDT - Nasdaq Real Time Price
| Prev Close: | 2.18 |
|---|
| Open: | 2.19 |
|---|
| Bid: | 2.06 x 200 |
|---|
| Ask: | 2.14 x 100 |
|---|
| 1y Target Est: | 3.63 |
|---|
| Beta: | -1.32 |
|---|
| Next Earnings Date: | 30-May-13 |
|---|
| Day's Range: | 2.11 - 2.21 |
|---|
| 52wk Range: | 1.90 - 4.78 |
|---|
| Volume: | 9,229 |
|---|
| Avg Vol (3m): | 34,091 |
|---|
| Market Cap: | 45.55M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.14 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013PR Newswire(Mon, May 20)
- Uroplasty Announces STEP Study 3-Year Results Demonstrate Sustained Therapeutic Effects Of Percutaneous Tibial Nerve StimulationPR Newswire(Fri, May 10)
- Uroplasty Inc. Stock Downgraded (UPI)at TheStreet(Tue, Apr 16)
- Linn Energy Gets a Thumbs Down and 2 More Analyst Downgrades to Knowat Wall St. Cheat Sheet(Mon, Apr 8)
- Uroplasty Announces CEO ResignationPR Newswire(Fri, Apr 5)
- UROPLASTY INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal OffEDGAR Online(Fri, Apr 5)
- Uroplasty To Present At The 25th Annual ROTH Growth Stock ConferencePR Newswire(Thu, Mar 7)
- Uroplasty Announces Several Presentations on Urgent® PC to be Delivered at Upcoming Professional Society MeetingsPR Newswire(Mon, Feb 25)
- Uroplasty Announces Executive Changes In US Sales OrganizationPR Newswire(Tue, Feb 5)
- UROPLASTY INC FinancialsEDGAR Online Financials(Wed, Jan 30)
- Rayonier Downgraded to Sector Perform and 3 Downgraded Stocks to Eyeat Wall St. Cheat Sheet(Fri, Jan 25)
- Nidec Sees Drastic Demand Decline and 2 Stocks HItting 52-Week Lowsat Wall St. Cheat Sheet(Fri, Jan 25)
- UROPLASTY INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, Jan 24)
- Uroplasty downgraded to Market Perform from Outperform at JMP Securitiestheflyonthewall.com(Tue, Jan 22)
- UROPLASTY INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, Oct 25)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 2.02 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Mar-13)
: | -0.16 |
|---|
| Quarterly EPS Est
(Mar-13)
: | -0.04 |
|---|
| Mean Recommendation*: | 2.7 |
|---|
| PEG Ratio (5 yr expected): | -0.53 |
|---|
Business Summary
Uroplasty, Inc., a medical device company, engages in the development, manufacture, and marketing of products for the treatment of voiding dysfunctions.
View More